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In this issue, Papouin et al. show that glycine is the endogenous coagonist for extrasynaptic NMDA
receptors (NMDARs), unlike at synapses where the coagonist is D-serine. By enzymatically degrad-
ing endogenous glycine, they begin to address the enigmatic physiological and pathological roles
for extrasynaptic NMDARs.N-methyl-D-aspartate glutamate recep-
tors (NMDARs) play key roles in synaptic
transmission, synaptic plasticity, and
learning and memory, and disturbances
in NMDAR function have been implicated
in a broad range of neuropsychiatric
disorders. NMDARs are unique among
neurotransmitter receptors in that they
require both glutamate and a coagonist
for activation. The coagonist was initially
identified as glycine (Johnson andAscher,
1987; Kleckner and Dingledine, 1988),
although subsequent evidence, largely
by Sol Snyder and colleagues, has re-
vealed that D-serine is similarly potent
and is found at high concentrations at
synapses in which NMDARs are preva-
lent. In a pioneering study, Mothet et al.
(2000) were the first to show that deple-
tion of endogenous D-serine considerably
reduces synaptic NMDAR currents, and it
is now generally accepted that glial-
derived D-serine is the endogenous coa-
gonist for synaptic NMDARs (Wolosker,
2007).
Neuronal NMDARs are also present
on nonsynaptic membranes, although
identification of clear physiological roles
for these extrasynaptic NMDARs has re-
mained elusive. There is, however, signif-
icant clinical interest in studying their
function and regulation given their poten-
tial involvement in the pathogenesis of
Alzheimer’s and Huntington’s disease
and in ischemic cell death (Hardingham
and Bading, 2010). Nevertheless, basic
essential questions regarding the activa-
tion of extrasynaptic NMDARs have re-
mained largely unresolved, including thesource of extrasynaptic glutamate, the
depolarization signal required to relieve
the Mg2+ block, as well as the identity
and source of the glycine site coagonist.
In this issue, Papouin et al. (2012) show
that glycine and D-serine are both endog-
enous coagonists for NMDARs but act
at distinct populations of receptors, with
D-serine present at synaptic NMDARs
and glycine at their extrasynaptic counter-
parts (Figure 1).
To assess the individual functions of
glycine and D-serine, the authors treat
hippocampal slices from adult rats with
D-amino acid oxidase (DAAO), which
specifically degrades D-amino acids,
such as D-serine, and a recombinant
glycine oxidase (GO) from Bacillus subtilis
to remove endogenous glycine. They
find that treatment with DAAO reduces
synaptic NMDAR responses by nearly
60%, confirming previous studies that
D-serine is themajor coagonist at synaptic
NMDARs. The remaining 40% of synaptic
NMDAR responses could be due to a
number of factors, including poor pene-
tration of the recombinant enzyme into
the slice preparation or insufficient
kinetics of D-serine oxidation (which they
favor), or due to additional coagonism by
glycine. To address the latter, they added
GO along with DAAO and saw no further
reduction in synaptic NMDAR responses,
suggesting that endogenous glycine is
not contributing. However, they also
show that glycine can act as a coagonist
at synaptic NMDARs by exogenous
administration of glycine and by pharma-
cological inhibition of perisynaptic glycineCell 1transporters. In both of these situations,
GO now results in a reduction of the
synaptic NMDAR response. These results
strongly support the existing literature
suggesting that D-serine is the predomi-
nant coagonist at synaptic NMDARs.
To look at extrasynaptic NMDARs, they
apply a brief puff of NMDA onto the
dendrites of patch-clamped, depolarized
pyramidal cells, which results in long-
lasting outward NMDAR-mediated cur-
rents. Although this method samples
both synaptic and extrasynaptic recep-
tors, they find that, in contrast to the
synaptic responses, both DAAO and GO
reduce these NMDA-evoked responses.
They then enrich the extrasynaptic contri-
bution to the NMDA-evoked responses by
blocking a portion of synaptic NMDARs
with the open-channel inhibitor MK-801
and show a greater effect of GO treat-
ment, further supporting their conclusion
that glycine acts as a coagonist at
extrasynaptic NMDARs. In addition, they
show GO-selective effects on the small,
tonic extrasynaptic NMDAR currents first
reported by Sah et al. (1989) and internally
consistent effects on GluN2 subunit-
selective antagonism. Taken together,
Papouin et al. convincingly, though not
definitively, show that glycine is a
major coagonist at extrasynaptic NMDA
receptors. Not fully answered is whether
D-serine contributes to the extrasynaptic
NMDAR responses. Indeed, it is uncertain
how D-serine is removed, as DAAO is at
low levels in the forebrain and no unam-
biguous transport mechanism has been
identified.50, August 3, 2012 ª2012 Elsevier Inc. 455
Figure 1. Synaptic and Extrasynaptic NMDA Receptors Use
Different Coagonists
NMDA receptors are unique among neurotransmitter receptors in that acti-
vation requires binding of both glutamate and a coagonist. Initially, this
coagonist was thought to be glycine (Johnson and Ascher, 1987), though over
the past decade it has become clear that, in many brain regions, synaptic
NMDA receptors utilize D-serine (Mothet et al., 2000) released by synapse-
enveloping astrocytes as coagonist. NMDA receptors are also found on
extrasynaptic membranes, though the physiological roles of these receptors
are poorly understood. Papouin et al. (2012) now show that glycine is themajor
coagonist at extrasynaptic NMDA receptors and is largely excluded from
synapses by perisynaptic glycine transporters. Enzymatic degradation of
ambient glycine now allows a dissection of the physiological roles for this
enigmatic class of NMDA receptors.These limitations aside, the
selectivity of GO for reduc-
ing extrasynaptic, but not
synaptic, NMDARs can be
used as a tool to begin to
probe the elusive physiolog-
ical and pathological roles
of the extrasynaptic popula-
tion of NMDARs. Along these
lines, Papouin et al. show that
long-term potentiation (LTP)
is blocked by D-serine deple-
tion but is unaffected by
decreasing glycine, whereas
long-term depression (LTD)
is blocked by either. Surpris-
ingly, glycine depletion
completely abolishes LTD,
whereas depletion of D-serine
only attenuates it, suggesting
that extrasynaptic NMDARs
are crucial for LTD induction.
However, it is uncertain
how extrasynaptic NMDARs
would get activated during
the low-frequency LTD induc-
tion protocol.
They next examined the
effects of glycine or D-serine
removal on NMDA-induced
neurotoxicity in hippocampal
slices. They again confirm
previous findings (Katsuki
et al., 2004) that DAAO treat-
ment is strongly protective
against NMDA-induced cell
death and additionally showJohnson, J.Wthat GO treatment does not prevent
neurotoxicity. These data support the
conclusion that synaptic rather than
extrasynaptic NMDARs mediate the
NMDA-induced neurotoxicity in CA1
pyramidal neurons. This result is in
striking contrast to a large body of litera-
ture in cultured neurons that posits that
activation of extrasynaptic NMDARs pro-
motes excitotoxicity (Hardingham and
Bading, 2010). It could be argued that
acute tissue slices more closely approxi-
mate intact brain, where differential roles
for synaptic and extrasynaptic NMDARs
have not been rigorously examined.
Finally, they provide the quite unex-
pected and compelling finding in cultured
neurons that glycine and D-serine differ-
entially affect the surface diffusion rate
of NMDARs in a subunit-dependent
manner. Specifically, exogenous applica-456 Cell 150, August 3, 2012 ª2012 Elseviertion of glycine selectively impairs the
surface diffusion of GluN2B-containing
NMDARs, whereas D-serine application
impairs the mobility of GluN2A-containing
receptors. Most surprising is that this
effect remains even after blocking
channel. These results suggest a unique
functional role for the glycine site coagon-
ist independent of channel gating but
leave the reader somewhat dangling, as
they provide no clues as to the basis of
this intriguing effect. An obvious experi-
ment would be to examine surface
mobility with transfected channel-dead
receptors.
In summary, Papouin et al. convincingly
demonstrate that glycine acts as a major
coagonist for extrasynaptic NMDARs in
the hippocampus and is excluded from
contributing to synaptic receptor activity.
Many questions remain. What advantageInc.is provided by anatomically
segregating the coagonists
for NMDARs? When is this
functional compartmentaliza-
tion solidified during neuronal
development, and what impli-
cations might this division
have on synaptogenesis?
Regardless, the findings will
now allow proposed roles
for extrasynaptic NMDARs
to be tested, including their
involvement in neuronal syn-
chrony (Fellin et al., 2004),
the shaping of synaptic
potentials prior to somatic
integration, and the de novo
synthesis of dendritic spines
(Kwon and Sabatini, 2011).
Finally, the findings may allow
the development of thera-
peutic approaches to en-
hance or inhibit extrasynaptic
NMDAR activation without
affecting synaptic transmis-
sion by targeting the glycine
regulatory machinery.REFERENCES
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